Marathon and Zafgen Add to Series B Rounds, Athenahealth and Sermo Announce Partnership, Sensata Sets IPO Terms, & More Boston-Area Deals News
Early round venture funding dominated the deals news this week, but there were still announcements of partnerships, acquisitions, and IPOs to mix it up.
—Newton, MA-based energy storage company General Compression announced it had closed more than $17 million in commitments to its Series A round, but did not reveal how much of that money was in new equity investments. The funding came from U.S. Renewables Group and Duke Energy, and will go to building the company’s first commercial-scale wind power storage unit.
—Marathon Technologies, a Littleton, MA maker of fault-tolerance software, brought its Series B funding round up to $13.5 million, thanks to a third close, a regulatory filing revealed last week.
—Stealthy life sciences startup Ra Pharmaceuticals raised $10.3 million of a planned $27.6 million round of equity-based financing, according to an SEC filing. The company is incubated at the Boston office of Morgenthaler Ventures and is lead by Doug Treco, who co-founded former Transkaryotic Therapies, a Cambridge, MA company acquired by Irish drugmaker Shire in 2005.
—Intrinsic Therapeutics raised $18 million of a $20 million round that included equity, options, and warrants. An SEC filing listed New Enterprise Associates, Spray Venture Partners, and New Leaf Venture Partners as directors of Woburn, MA-based Intrinsic, which develops spinal implants to treat disc herniation.
—-Athenahealth, a Watertown, MA-based maker of Internet software for medical practices, and doctors-only social networking company Sermo announced a partnership early this week, but didn’t disclose financial terms of the deal. Athena plans on … Next Page »